Regulatory Statement: For Research Use Only. Not for any animal or human therapeutic or diagnostic use. Cleavage: No Cleavage Site Vector Type: pENTR Product Size: 10 µg Cloning Method: Gateway® Protein Tag or Fusion: Untagged Antibiotic Resistance (Bacterial): Kanamycin (KanR), Chloramphenicol (CmR) Gateway® entry vectors are designed to clone DNA sequences using restriction endonucleases and ligase to create a Gateway® entry clone. The resulting entry clone is ready for recombination with a destination vector to create an expression clone. New: pENTR™ Dual Selection vectors